Olorinab Eases Abdominal Pain Associated with Crohn’s Disease in Phase 2a Trial
News
Olorinab, an investigational compound being developed by Arena Pharmaceuticals, significantly reduced chronic abdominal pain in patients with Crohn’s disease, according to topline results from a Phase 2a clinical trial. The findings also ... Read more